Champions Oncology, Inc. (CSBR) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 16.56M | 15.04M | 13.99M | 12.36M | 17.04M | 13.49M | 14.06M | 14M | 12.02M | 11.57M | 12.56M | 13.07M | 12.77M | 14.28M | 13.74M | 12.88M | 13.19M | 11.79M | 11.25M | 10.56M |
| Revenue Growth % | -2.82% | 11.46% | -0.47% | -11.76% | 41.77% | 16.56% | 11.94% | 7.12% | -5.9% | -18.96% | -8.61% | 1.51% | -3.18% | 21.17% | 22.15% | 21.9% | 22.02% | 16.5% | 17.88% | 20.76% |
| Cost of Goods Sold | 8.83M | 7.26M | 8M | 7.27M | 6.62M | 7.43M | 7.07M | 7.25M | 7.85M | 6.62M | 7.68M | 7.34M | 7.7M | 7.44M | 7.05M | 6.22M | 6.41M | 5.61M | 5.4M | 5.62M |
| COGS % of Revenue | 53.35% | 48.3% | 57.13% | 58.85% | 38.83% | 55.07% | 50.3% | 51.78% | 65.3% | 57.18% | 61.17% | 56.14% | 60.28% | 52.12% | 51.31% | 48.31% | 48.56% | 47.59% | 47.95% | 53.24% |
| Gross Profit | 7.72M | 7.77M | 6M | 5.08M | 10.42M | 6.06M | 6.99M | 6.75M | 4.17M | 4.96M | 4.88M | 5.73M | 5.07M | 6.84M | 6.69M | 6.66M | 6.79M | 6.18M | 5.86M | 4.94M |
| Gross Margin % | 46.65% | 51.7% | 42.87% | 41.15% | 61.17% | 44.93% | 49.7% | 48.22% | 34.7% | 42.82% | 38.83% | 43.86% | 39.72% | 47.88% | 48.69% | 51.69% | 51.44% | 52.41% | 52.05% | 46.76% |
| Gross Profit Growth % | -25.88% | 28.25% | -14.15% | -24.7% | 149.93% | 22.32% | 43.31% | 17.77% | -17.82% | -27.54% | -27.13% | -13.87% | -25.24% | 10.7% | 14.27% | 34.74% | 9.66% | 38.1% | 39.12% | 29.18% |
| Operating Expenses | 7.91M | 7.59M | 6.51M | 6.8M | 5.92M | 5.33M | 5.66M | 7.02M | 6.75M | 6.91M | 7.43M | 8.25M | 7.53M | 6.83M | 6.98M | 6.97M | 5.96M | 5.91M | 6.03M | 5.37M |
| OpEx % of Revenue | 47.78% | 50.47% | 46.5% | 55.02% | 34.76% | 39.51% | 40.25% | 50.16% | 56.14% | 59.71% | 59.14% | 63.15% | 58.97% | 47.83% | 50.76% | 54.1% | 45.15% | 50.18% | 53.6% | 50.82% |
| Selling, General & Admin | 5.64M | 4.97M | 4.42M | 4.83M | 4.2M | 3.64M | 4.21M | 4.54M | 4.56M | 4.39M | 4.64M | 4.59M | 4.33M | 4.23M | 4.09M | 4.38M | 3.78M | 3.62M | 3.73M | 3.3M |
| SG&A % of Revenue | 34.07% | 33.07% | 31.62% | 39.13% | 24.67% | 26.98% | 29.91% | 32.41% | 37.95% | 37.98% | 36.91% | 35.15% | 33.9% | 29.6% | 29.76% | 33.98% | 28.62% | 30.67% | 33.13% | 31.22% |
| Research & Development | 2.27M | 2.62M | 2.08M | 1.96M | 1.72M | 1.69M | 1.45M | 2.05M | 2.19M | 2.52M | 2.79M | 2.85M | 3.2M | 2.6M | 2.89M | 2.59M | 2.18M | 2.3M | 2.3M | 2.07M |
| R&D % of Revenue | 13.71% | 17.4% | 14.88% | 15.89% | 10.09% | 12.52% | 10.34% | 14.63% | 18.19% | 21.73% | 22.24% | 21.82% | 25.07% | 18.23% | 21% | 20.11% | 16.53% | 19.51% | 20.47% | 19.59% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 435K | 0 | 0 | 0 | 807K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -187K | 185K | -507K | -1.71M | 4.5M | 732K | 1.33M | -271K | -2.58M | -1.96M | -2.55M | -2.52M | -2.46M | 7K | -284K | -311K | 830K | 263K | -175K | -429K |
| Operating Margin % | -1.13% | 1.23% | -3.62% | -13.87% | 26.4% | 5.43% | 9.45% | -1.94% | -21.44% | -16.89% | -20.32% | -19.29% | -19.24% | 0.05% | -2.07% | -2.42% | 6.29% | 2.23% | -1.56% | -4.06% |
| Operating Income Growth % | -104.16% | -74.73% | -138.15% | -532.47% | 274.58% | 137.44% | 152.08% | 89.25% | -4.84% | -28028.57% | -798.59% | -710.61% | -396.14% | -97.34% | -62.29% | 27.51% | -15.48% | 3657.14% | -829.17% | 77.56% |
| EBITDA | 154K | 542K | -149K | -1.32M | 4.9M | 1.13M | 1.78M | 186K | -2.1M | -1.47M | -2.11M | -1.94M | -1.88M | 567K | 244K | 257K | 1.23M | 609K | 142K | -126K |
| EBITDA Margin % | 0.93% | 3.6% | -1.06% | -10.68% | 28.74% | 8.38% | 12.64% | 1.33% | -17.44% | -12.71% | -16.77% | -14.83% | -14.74% | 3.97% | 1.78% | 2% | 9.29% | 5.17% | 1.26% | -1.19% |
| EBITDA Growth % | -96.86% | -52.08% | -108.38% | -809.68% | 333.64% | 176.89% | 184.39% | 109.6% | -11.31% | -359.44% | -963.52% | -854.09% | -253.59% | -6.9% | 71.83% | 303.97% | -4.14% | 93.95% | -52.82% | 92.44% |
| D&A (Non-Cash Add-back) | 341K | 357K | 358K | 394K | 398K | 399K | 449K | 457K | 481K | 484K | 445K | 583K | 575K | 560K | 528K | 568K | 396K | 346K | 317K | 303K |
| EBIT | -237K | 255K | -452K | -1.96M | 4.52M | 739K | 1.33M | 164K | -2.52M | -2.06M | -2.54M | -1.71M | -2.42M | -2K | -302K | -346K | 798K | 289K | -158K | -429K |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -50K | 70K | 55K | -250K | 19K | 7K | 5K | 81K | 58K | -105K | 14K | -20K | 36K | -9K | -18K | -35K | -32K | 26K | 17K | 7K |
| Pretax Income | -237K | 255K | -452K | -1.96M | 4.52M | 739K | 1.33M | -190K | -2.52M | -2.06M | -2.54M | -2.54M | -2.42M | -2K | -302K | -346K | 798K | 289K | -158K | -422K |
| Pretax Margin % | -1.43% | 1.7% | -3.23% | -15.9% | 26.52% | 5.48% | 9.49% | -1.36% | -20.96% | -17.8% | -20.21% | -19.44% | -18.96% | -0.01% | -2.2% | -2.69% | 6.05% | 2.45% | -1.4% | -3.99% |
| Income Tax | 42K | 18K | 14K | -129K | 23K | 11K | 21K | -81K | 11K | 11K | 28K | 20K | 17K | 14K | 17K | -2K | 11K | 12K | 14K | 32K |
| Effective Tax Rate % | -17.72% | 7.06% | -3.1% | 6.57% | 0.51% | 1.49% | 1.57% | 42.63% | -0.44% | -0.53% | -1.1% | -0.79% | -0.7% | -700% | -5.63% | 0.58% | 1.38% | 4.15% | -8.86% | -7.58% |
| Net Income | -279K | 299K | -466K | -1.83M | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M | -2.44M | -16K | -319K | -344K | 787K | 277K | -172K | -454K |
| Net Margin % | -1.68% | 1.99% | -3.33% | -14.85% | 26.38% | 5.4% | 9.34% | -0.78% | -21.05% | -17.9% | -20.43% | -19.59% | -19.1% | -0.11% | -2.32% | -2.67% | 5.97% | 2.35% | -1.53% | -4.3% |
| Net Income Growth % | -106.21% | -58.93% | -135.49% | -1583.49% | 277.67% | 135.15% | 151.17% | 95.74% | -3.73% | -12843.75% | -704.39% | -644.48% | -409.91% | -105.78% | -85.47% | 24.23% | -17.94% | 27600% | -329.33% | 77.82% |
| Net Income (Continuing) | -279K | 237K | -466K | -1.83M | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M | -2.44M | -16K | -319K | -344K | 787K | 277K | -172K | -454K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 95K | 61K | 30K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.02 | 0.02 | -0.03 | -0.13 | 0.31 | 0.05 | 0.09 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | -0.00 | -0.02 | -0.03 | 0.05 | 0.02 | -0.01 | -0.04 |
| EPS Growth % | -106.45% | -64.35% | -133.8% | - | 263.16% | 134.6% | 149.21% | 95.79% | -5.56% | - | -705.08% | -645.1% | -429.07% | -106.32% | -84.38% | 28.97% | -17.25% | - | - | 77.56% |
| EPS (Basic) | -0.02 | 0.02 | -0.03 | -0.13 | 0.33 | 0.05 | 0.10 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | -0.00 | -0.02 | -0.03 | 0.06 | 0.02 | -0.01 | -0.04 |
| Diluted Shares Outstanding | 13.89M | 14.46M | 13.79M | 13.75M | 14.36M | 14.02M | 14.04M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.56M | 13.53M | 13.52M | 13.51M | 14.39M | 14.55M | 13.4M | 13.4M |
| Basic Shares Outstanding | 13.89M | 13.79M | 13.79M | 13.75M | 13.7M | 13.59M | 13.59M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.55M | 13.53M | 13.52M | 13.28M | 13.5M | 13.43M | 13.4M | 13.4M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |